Lupus anticoagulant in human immunodeficiency virus–infected patients on highly active antiretroviral therapy

dc.contributor.authorAwodu, O.A.
dc.contributor.authorOlayemi, E.E.
dc.contributor.authorBazuaye, G.N.
dc.contributor.authorOnunu, A.N.
dc.date.accessioned2012-05-16T12:22:03Z
dc.date.accessioned2017-10-19T11:54:25Z
dc.date.available2012-05-16T12:22:03Z
dc.date.available2017-10-19T11:54:25Z
dc.date.issued2010
dc.description.abstractLupus anticoagulant (LA) is a heterogeneous group of antibodies that causes a variety of clinical and laboratory effects; has been described in infections such as human immunodeficiency virus. LA has not been previously described in Nigerians with human immunodeficiency virus infection on highly active antiretroviral therapy (HAART).en_US
dc.identifier.urihttp://197.255.68.203/handle/123456789/1394
dc.language.isoenen_US
dc.publisherIndian J Pathol Microbiol 53(1): 47-9en_US
dc.titleLupus anticoagulant in human immunodeficiency virus–infected patients on highly active antiretroviral therapyen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: